ESCRS Homepage

June 2002
IN THIS ISSUE

Latanoprost a safe and effective alternative


Stable Outcomes with Zyoptix-guided LASIK

Research updates at three ESCRS Symposia, Nice

Long-term effects on lacrimal gland function experienced with high dose radioiodine therapy

Controversy grows over use of orbital radiotherapy in treatment of thyroid eye disease

LASIK is rarely a good idea in thyroid patients

Researchers point towards new approach in early
detection of thyroid-associated ophthalmopathy

Shiley Thyroid Eye Clinic adopts team approach

Thyroid surgery techniques evolve to treat patient upsurge

Botulinum toxin injection controls crocodile tears

Outpatient is in and inpatient is out in Germany

Microkeratomes: Go low and go slow for higher precision

Study reveals flaps created using Nidek Microkeratome
are closer to target and more predictable

New LASIK instruments may reduce flap complications

Watch for factors leading to post-LASIK vision quality complaints

Increasing options for keratoconus patients

OKULIX software reduces IOL calculation errors

Unoprostone useful adjunct to maximal medical therapy

Treating periocular pain offers relief to some migraine sufferers

Never is better than late for silicone IOL implantation

Two options better than one for amblyopia

Grafted stem cells team up with natives

Sourdille calls for LASIK standardisation

FEATURES
From The Editor
Bio-ophthalmology
Outlook on Industry
In Your Good Books
Regulatory Matters



Treating periocular pain offers relief to some migraine sufferers

By Sean Henahan

Madrid — Local treatment of inflammation of the superior oblique muscle trochlea appears to offer significant relief to some migraine sufferers, according to a Spanish study.

Julio Yangüela Rodilla MD and colleagues from the Headache Program, Fundación Hospital Alcorcon, Madrid, Spain identified five patients with trochleitis associated with chronic migraine headaches.

The five female patients reported that the onset of pain around the area of the eye socket caused their migraines to worsen for periods ranging from several hours to several days. They described the headache pain in terms ranging from “dull” to “excruciating”.

Dr Yangüela Rodilla treated the trochleitis with local injections of 3.0 mg of dexamethasone and 3.0 mg methylprednisolone applied directly to the inflamed trochlear area.

The treatment relieved the ocular pain and improved control of associated migraine symptoms within 48-72 hours in all cases. All patients experienced relief of both ocular pain an migraine after a course of treatment, with one reporting complete relief. The other four patients reported lasting relief after a second course of treatment.

After treatment all patients decreased basal pain, number of attacks and medication intake to control chronic migraine.

The diagnosis of trochleitis was based on the presence of periorbital pain appearing synchronously with and ipsilateral to the demonstrated sore trochlea. Additional diagnostic criteria included palpation of a swollen trochlea and obvious trochlea tenderness. In such cases, there is an exacerbation of pain upon palpation of the trochlea or when attempting supraduction of the symptomatic eye.

The differential diagnosis of idiopathic trochleitis includes thyroid ophthalmopathy, carotid cavernous sinus fistula, arteriovenous malformation, orbital myositis and infiltration of extraocular muscle by metastatic tumor, sarcoidosis or lymphoma. The absence of other signs including conjunctival injection, chemosis, proptosis and periorbital edema can aid in the differential diagnosis.

Other causes of ocular pain such as cluster headache, SHUNT or optic neuritis should also be excluded.

Although rare, trochleitis can also occur in rheumatoid arthritis, systemic lupus erythematosus, psoriasis or enteropathic arthropathy. Laboratory testing and imaging studies are required to confirm the diagnosis.

The study indicates a new treatable trigger mechanism in chronic migraine.
Authors suggest that trochlear area should be explored in all patients referring periorbital pain or migraine associated with ocular pain.

Dr Yangüela Rodilla's study appeared in Neurology (2002;58:802–805), the scientific journal of the American Academy of Neurology .

Top